Declan Doogan - Nov 29, 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ Jim Engelhart, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Nov 29, 2021
Transactions value $
-$2,766,433
Form type
4
Date filed
12/1/2021, 06:24 PM
Previous filing
Nov 17, 2021
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Sale -$1.46M -13K -1.46% $112.40* 882K Nov 29, 2021 Direct F1
transaction BHVN Common Shares Sale -$1.3M -11.5K -1.3% $113.25* 871K Nov 29, 2021 Direct F2
holding BHVN Common Shares 626K Nov 29, 2021 By the Declan Doogan 2014 Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.92 - $112.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.92 - $113.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.